BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced
Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans,
Leading Midwest healthcare system reports significant cost savings and noise reduction following evaluation of the PURE EP™ System
Medical center signs agreement to acquire the Company's digital